Evolving diagnostic criteria for multiple myeloma.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] 12. Haematologica. 2023 Nov 1;108(11):3160-3164. doi: 10.3324/haematol.2022.282214. Chemotherapy in solitary bone plasmacytoma to prevent evolution to multiple myeloma. Ascione S(1), Harel S(2), Besson FL(3), Belkhir R(1), Henry J(1), Royer B(2), Arnulf B(2), Mariette X(4), Seror R(5). Author information: (1)Department of Rheumatology, AP-HP, Hôpital Bicêtre, Le Kremlin Bicêtre. (2)Department of Immunohematology, AP-HP, Hôpital Saint-Louis, Paris. (3)Department of Biophysics and Nuclear Medicine-Molecular Imaging, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France; Université Paris-Saclay, CEA, CNRS, Inserm, BioMaps, Orsay, 91401. (4)Department of Rheumatology, AP-HP, Hôpital Bicêtre, Le Kremlin Bicêtre, France; Center of Immunology of Viral Infections and Auto-immune Diseases (IMVA), INSERM UMR1184, Université Paris-Saclay, Le Kremlin Bicêtre. (5)Department of Rheumatology, AP-HP, Hôpital Bicêtre, Le Kremlin Bicêtre, France; Center of Immunology of Viral Infections and Auto-immune Diseases (IMVA), INSERM UMR1184, Université Paris-Saclay, Le Kremlin Bicêtre. raphaele.seror@aphp.fr. DOI: 10.3324/haematol.2022.282214 PMCID: PMC10620568